Liu Chang, Yang Zhou, Tang Xiance, Zhao Fangfang, He Mengke, Liu Changpeng, Zhou Dongmin, Wang Lifeng, Gu Bo, Yuan Yiqiang, Chen Xiaobing
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510280, China.
Department of Critical Care Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, 450008, China.
Thromb J. 2023 Jan 4;21(1):2. doi: 10.1186/s12959-022-00447-2.
Fusobacterium nucleatum (F. nucleatum) often colonizes cancerous gastric tissues and is characterized by the promotion of platelet aggregation and the development of visceral thrombosis. Venous thromboembolism (VTE) leads to a significant increase in the mortality of gastric cancer (GC) patients. However, the relationship between the colonization of F. nucleatum and the prognosis of GC patients is still unknown.
The aim of this study was to explore whether the colonization of F. nucleatum is related to the prognosis of GC patients complicated with VTE and to explore other potential risk factors.
From 2017-2021, the data of 304 patients with new VTEs during the treatment of GC at the Affiliated Cancer Hospital of Zhengzhou University were collected. Fluorescence in situ hybridization of F. nucleatum was performed on pathological sections of cancer tissues from the patients. Survival analysis methods, including the Kaplan‒Meier method and Cox proportional hazard model, were performed.
F. nucleatum colonization was significantly associated with splanchnic vein thrombosis, higher platelet-lymphocyte ratio (PLR), and lower absolute lymphocyte count. In the multivariable Cox model, F. nucleatum colonization was found to be an independent risk factor for the prognosis of GC, with an adjusted HR of 1.77 (95% CI, 1.17 to 2.69 [P = 0.007]). In addition, patients with high PLR (HR: 2.65, P = 0.004) or VTE occurring during four cycles of chemotherapy (HR: 2.32, P = 0.012) exhibited shorter survival. Conversely, those experiencing VTE later (HR per month from diagnosis of GC: 0.95, P = 0.006) or using IVC filters (HR: 0.27, P = 0.011) had longer survival.
Colonization of F. nucleatum in GC tissues was associated with lower absolute lymphocyte count and higher PLR in GC patients with VTE. F. nucleatum colonization also appeared to be associated with the development of VTE in specific sites, in particular the splanchnic vein. Colonization of F. nucleatum may potentially represent an independent predictor of poor prognosis in GC patients. Additional research is necessary to validate these findings.
具核梭杆菌(F. nucleatum)常定植于癌性胃组织,其特征是促进血小板聚集和内脏血栓形成。静脉血栓栓塞症(VTE)导致胃癌(GC)患者死亡率显著增加。然而,具核梭杆菌定植与GC患者预后之间的关系仍不清楚。
本研究旨在探讨具核梭杆菌定植是否与合并VTE的GC患者预后相关,并探索其他潜在危险因素。
收集2017年至2021年期间郑州大学附属肿瘤医院304例GC治疗期间新发VTE患者的数据。对患者癌组织病理切片进行具核梭杆菌的荧光原位杂交。采用生存分析方法,包括Kaplan-Meier法和Cox比例风险模型。
具核梭杆菌定植与内脏静脉血栓形成、较高的血小板-淋巴细胞比值(PLR)和较低的绝对淋巴细胞计数显著相关。在多变量Cox模型中,具核梭杆菌定植被发现是GC预后的独立危险因素,调整后的HR为1.77(95%CI,1.17至2.69 [P = 0.007])。此外,PLR高的患者(HR:2.65,P = 0.004)或在四个化疗周期内发生VTE的患者(HR:2.32,P = 0.012)生存期较短。相反,VTE发生较晚的患者(自GC诊断起每月HR:0.95,P = 0.006)或使用下腔静脉滤器的患者(HR:0.27,P = 0.011)生存期较长。
GC组织中具核梭杆菌定植与合并VTE的GC患者较低的绝对淋巴细胞计数和较高的PLR相关。具核梭杆菌定植似乎也与特定部位VTE的发生有关,特别是内脏静脉。具核梭杆菌定植可能是GC患者预后不良的独立预测因素。需要进一步研究来验证这些发现。